Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Stingray Therapeutics
company
About
Stingray Therapeutics is a biotech company that develops immunotherapies to treat various types of cancer.
- 1 - 10
Highlights
Details
- Last Funding Type
- Non-Equity Assistant
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2018
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Stingray Therapeutics is a biotech company that develops immunotherapies to treat various types of cancer.The company was founded in 2018 and is based in Houston, Texas.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Stingray Therapeutics has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Oct 1, 2020 from a Non-Equity Assistant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 1, 2020 | Non-Equity Assistant | — | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Stingray Therapeutics is funded by 1 investors.
Newchip
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Newchip
|
— | Non-Equity Assistant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
